Aytu Biopharma AYTU
NASDAQ AYTU
$2.07 -0.02 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Return on Assets [ROA] (2011 - 2026)

Updated

Aytu Biopharma's Return on Assets [ROA] came in at -13.15% for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 2.23 percentage points from -10.92% a year earlier but up 15.99 percentage points from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Return on Assets [ROA] was -12.44%, down 1.24 percentage points from FY2025.

  • Return on Assets [ROA] carries a five-year change of +15.39 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Assets [ROA] was -11.20% in FY2025 (+1.25 pp), -12.45% in FY2024 (-0.01 pp), -12.44% in FY2023 (+41.50 pp) and -53.95% in FY2022 (-26.12 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -70.99% (fiscal Q4 2022) to 1.36% (fiscal Q3 2025).
  • Year-over-year, Return on Assets [ROA] has declined for four consecutive quarters, with an average year-over-year change of -2.18 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q4 2023 (a gain of 58.97 percentage points), and the weakest in fiscal Q4 2022 (a drop of 49.39 percentage points).
  • Business Quant data shows AYTU's Return on Assets [ROA] at -29.15% (Q3 2026), -19.79% (Q2 2026) and -10.49% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Aytu Biopharma 22.49 Mn -93.18 Mn 10.41 Mn -13.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.15%
Mar 31, 2026 -29.15%
Dec 31, 2025 -19.79%
Sep 30, 2025 -10.49%
Jun 30, 2025 -10.92%
Mar 31, 2025 1.36%
Dec 31, 2024 -4.52%
Sep 30, 2024 -5.34%
Jun 30, 2024 -12.83%
Mar 31, 2024 -10.52%
Dec 31, 2023 -13.63%
Sep 30, 2023 -18.17%
Jun 30, 2023 -12.02%
Mar 31, 2023 -21.26%
Dec 31, 2022 -52.69%
Sep 30, 2022 -56.76%
Jun 30, 2022 -70.99%
Mar 31, 2022 -56.76%
Dec 31, 2021 -37.03%
Sep 30, 2021 -33.07%
API Access

Aytu Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEY